Evidence map›Paper›PMID 42010357›Full record

ArticleNature reviews. Cardiology2026

Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce cardiovascular risk.

Yu Mi Kang, Josephine Harrington, Vanita R Aroda, Darren K McGuire

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT07567378. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07567378 not yet recruiting

Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts (CARTIZ): A Prospective Observational Multi-Institutional Registry of the VAT-Articular-Cardiac-Aging Axis in Adults Exposed to Tirzepatide in Mexico, With Quantitative Knee Cartilage T2 Mapping, Cardiac CT Epicardial Adipose Tissue Radiomic Phenotyping, HLA Stratification, Longitudinal Multi-Frequency Bioimpedance Body Composition, and a Prespecified Surgical Tissue Acquisition Subcohort

Ran2026Enrolled30Registered outcomes14Posted comparisons0ConditionsAtrial Fibrillation (AF), Coronary Artery Disease, Diabetes (DM), Heart FailureArmsTirzepatide
PMID 41406444PMID 40903131PMID 41666927PMID 38878772PMID 39566869PMID 41944220PMID 28701474PMID 30170852PMID 32154773PMID 41903163PMID 41928037other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu Mi KangDivision of Endocrinology, Diabetes, and Metabolism, Mass General Brigham and Harvard Medical School, Boston, MA, USA. ymkang@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-6272-0666
Josephine HarringtonDivision of Cardiology, University of Colorado, UC Health Heart & Vascular Center and the Colorado Prevention Center, Aurora, CO, USA.
Vanita R ArodaDivision of Endocrinology, Diabetes, and Metabolism, Mass General Brigham and Harvard Medical School, Boston, MA, USA.
Darren K McGuireUniversity of Texas Southwestern Medical Center and Parkland Health System, Dallas, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42010357

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.